Holly Holliday

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

On the origins of childhood cancer.

On the origins of childhood cancer.

Journal: Cancer metastasis reviews

Published: February 09, 2026

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.

Journal: Science translational medicine

Published: January 14, 2026

Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Journal: Cancer research

Published: March 24, 2025

Germline analysis of an international cohort of pediatric diffuse midline glioma patients.

Germline analysis of an international cohort of pediatric diffuse midline glioma patients.

Journal: Neuro-oncology

Published: March 12, 2025

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.

Journal: Neuro-oncology

Published: February 12, 2025

RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.

RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.

Journal: Cell death & disease

Published: January 02, 2025

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.

Journal: Science advances

Published: July 03, 2024

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 17, 2024

Signalling pathway crosstalk stimulated by L-proline drives mouse embryonic stem cells to primitive-ectoderm-like cells.

Signalling pathway crosstalk stimulated by L-proline drives mouse embryonic stem cells to primitive-ectoderm-like cells.

Journal: Development (Cambridge, England)

Published: February 14, 2023

β-cell function is regulated by metabolic and epigenetic programming of islet-associated macrophages, involving Axl, Mertk, and TGFβ receptor signaling.

β-cell function is regulated by metabolic and epigenetic programming of islet-associated macrophages, involving Axl, Mertk, and TGFβ receptor signaling.

Journal: iScience

Published: September 27, 2022

Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.

Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape.

Journal: Cancers

Published: October 19, 2021

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 01, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026